Mihaela Druta, MD

Vice Chair Sarcoma Department
Moffitt Cancer Center & Research Institute
Tampa, Florida, United States

Disclosure information not submitted.

Presentation(s):

• Paper 24 - A PHASE IB STUDY TO EVALUATE THE FEASIBILITY OF NIVOLUMAB OR NIVOLUMAB WITH AZACITIDINE IN PATIENTS WITH RECURRENT, RESECTABLE OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 86 - TRANSLATIONAL ANALYSES REVEAL MECHANISMS OF AFAMI-CEL'S ANTI-TUMOR ACTIVITY IN SYNOVIAL SARCOMA

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST